ABN AMRO Investment Solutions’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-17,062
Closed -$1.26M 437
2023
Q4
$1.26M Buy
17,062
+255
+2% +$16.7K 0.02% 288
2023
Q3
$1.15M Buy
16,807
+9,286
+123% +$788K 0.02% 290
2023
Q2
$706K Buy
+7,521
New +$587K 0.01% 312

Other funds holding EXAS

ABN AMRO Investment Solutions's EXAS Position: Q1 2024 in Review

ABN AMRO Investment Solutions sold out of Exact Sciences (EXAS) in Q1 2024, closing a stake of 17,062 shares — an estimated $1.26M sold.

ABN AMRO Investment Solutions first reported a position in EXAS in Q2 2023 and held it in 3 quarters. The position peaked at $1.26M in Q4 2023. 627 funds tracked by Wall St. Rank hold EXAS as of Q1 2024.

  • ABN AMRO Investment Solutions reported no remaining Exact Sciences position as of Q1 2024 after selling out during the quarter.
  • ABN AMRO Investment Solutions sold 17,062 Exact Sciences shares in Q1 2024, an estimated $1.26M.
  • ABN AMRO Investment Solutions first reported a position in Exact Sciences in Q2 2023 and held it in 3 quarters.
  • ABN AMRO Investment Solutions's Exact Sciences position peaked at $1.26M in Q4 2023.
  • 627 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2024.

Based on ABN AMRO Investment Solutions's 13F filing for Q1 2024, filed 5 Sep 2025.